AroCell AB (AROC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.010x

Based on the latest financial reports, AroCell AB (AROC) has a cash flow conversion efficiency ratio of -0.010x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.11 Million ≈ $-119.67K USD) by net assets (Skr108.87 Million ≈ $11.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check AroCell AB (AROC) strategic investment index to assess the company's strategic physical and investment asset allocation.

AroCell AB - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how AroCell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. See AROC book value for net asset value and shareholders' equity analysis.

AroCell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AroCell AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sarama Resource V:SWA	0.464x
Chibougamau Independent Mines Inc V:CBG	0.012x
BioLineRx Ltd NASDAQ:BLRX	-0.138x
Spolytech Co. Ltd KQ:050760	0.084x
Imexhs Ltd AU:IME	-0.103x
Vishwaraj Sugar Industries Limited NSE:VISHWARAJ	-0.120x
Mynd.ai, Inc. NYSE MKT:MYND	-0.360x
Future Retail Limited NSE:FRETAIL	1.043x

Annual Cash Flow Conversion Efficiency for AroCell AB (2011–2024)

The table below shows the annual cash flow conversion efficiency of AroCell AB from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is AroCell AB worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr121.20 Million ≈ $13.04 Million	Skr-2.36 Million ≈ $-253.76K	-0.019x	+76.30%
2023-12-31	Skr163.65 Million ≈ $17.61 Million	Skr-13.44 Million ≈ $-1.45 Million	-0.082x	-33.52%
2022-12-31	Skr222.69 Million ≈ $23.97 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.061x	+52.59%
2021-12-31	Skr217.45 Million ≈ $23.40 Million	Skr-28.21 Million ≈ $-3.04 Million	-0.130x	+61.39%
2020-12-31	Skr56.26 Million ≈ $6.05 Million	Skr-18.90 Million ≈ $-2.03 Million	-0.336x	-79.44%
2019-12-31	Skr80.41 Million ≈ $8.65 Million	Skr-15.06 Million ≈ $-1.62 Million	-0.187x	+37.79%
2018-12-31	Skr54.51 Million ≈ $5.87 Million	Skr-16.41 Million ≈ $-1.77 Million	-0.301x	+7.78%
2017-12-31	Skr46.68 Million ≈ $5.02 Million	Skr-15.24 Million ≈ $-1.64 Million	-0.326x	-188.96%
2016-12-31	Skr63.46 Million ≈ $6.83 Million	Skr-7.17 Million ≈ $-771.34K	-0.113x	+10.05%
2015-12-31	Skr72.69 Million ≈ $7.82 Million	Skr-9.13 Million ≈ $-982.27K	-0.126x	+76.77%
2011-12-31	Skr4.80 Million ≈ $516.22K	Skr-2.59 Million ≈ $-279.05K	-0.541x	--

About AroCell AB

ST:AROC Sweden Diagnostics & Research

Market Cap

$13.39 Million

Skr124.39 Million SEK

Market Cap Rank

#26314 Global

#569 in Sweden

Share Price

Skr0.54

Change (1 day)

+1.12%

52-Week Range

Skr0.50 - Skr0.59

All Time High

Skr15.05